Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials

Abstract Background A model was built that characterized effects of individual factors on five-year prostate cancer (PCa) risk in the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial (PLCO) and the Selenium and Vitamin E Cancer Prevention Trial (SELECT). This model was validated in a third...

Full description

Bibliographic Details
Main Authors: Jonathan A. Gelfond, Brian Hernandez, Martin Goros, Joseph G. Ibrahim, Ming-Hui Chen, Wei Sun, Robin J. Leach, Michael W. Kattan, Ian M. Thompson, Donna Pauler Ankerst, Michael Liss
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Urology
Subjects:
Prostate cancer
High grade prostate cancer
Risk prediction
Five-year risk
Online Access:https://doi.org/10.1186/s12894-022-00986-w

Internet

https://doi.org/10.1186/s12894-022-00986-w

Similar Items